& Labrou, N
October 2023: JAMA Research Letter Warns of Possible Ozempic Risks A research letter filed in the Journal of the American Medical Association alleges the risk of adverse gastrointestinal events associated with the use of GLP-1 agonists that are used not only to treat diabetes but also off-label for weight loss
Start with education, build a plan, and consult with a qualified provider before starting any protocol
And then if you have a BMI of 27 or above and have either pre-diabetes, a prior heart attack, a prior stroke or significant peripheral arterial disease, you will also qualify
Navy Veteran Experienced Healthcare Professional Nick Pasteur, MD West Division Physician Lead Telehealth Addiction Treatment Yesenia Aicardi, ARNP, FNP-C Family Nurse Practitioner Weight Management & Integrative Health Weight loss FAQs Important safety information What you should know before taking GLP-1s
Here are some stars who have admitted to taking the medication for weight loss and others who have vehemently denied taking it